Lv11
30 积分 2022-07-04 加入
A bispecific antibody targeting HER2 and CLDN18.2 eliminates gastric cancer cells expressing dual antigens by enhancing the immune effector function
2小时前
已完结
Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies
10天前
已完结
Targeting HER2 heterogeneity in breast and gastrointestinal cancers
2个月前
已完结
Effect of maturation at birth on the clinical features of neonatal cow's milk protein allergy: A retrospective study
6个月前
已完结
Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer
10个月前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
10个月前
已完结
皖公网安备34019202002308
